NUCLEASE PROBE TECHNOLOGIES
Live / Registered — Registered (as of 16 Jan 2024)
What this means for you
Registered since 16 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97182177
- Registration number
- 7281241
- Mark type
- Stylized text
- Filed
- 21 Dec 2021
- Registered
- 16 Jan 2024
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic test kits for sample analysis, namely, medical diagnostic kits comprised of reagents and assays that include molecular probes or microbiological culture media that includes molecular probes for analysis of biological samples for medical and veterinary purposes; medical diagnostic test kits comprised of reagents and assays that include molecular probes or microbiological culture media that includes molecular probes for sample analysis of bodily fluids, blood, skin cells, and tissues in humans and animals for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers and skin conditions; medical diagnostic test kits comprised of reagents and assays for testing of biological samples, namely, bodily fluids, blood, skin cells, and tissues in humans and animals for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers, and skin infections; diagnostic tools, namely, medical diagnostic reagents and assays for testing of samples for use in disease detection, namely, bacterial infections, fungal infections, antibiotic-resistant bacterial infections, bloodstream pathogens, cancers and skin infections
Owner
- Nuclease Probe Technologies, Inc., Belmont, MA, US
- Nuclease Probe Technologies, Inc., Belmont, MA, US
Prosecution history
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 27 Jul 2023 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 23 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 May 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 24 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 May 2023 — NON-FINAL ACTION E-MAILED
- 24 May 2023 — NON-FINAL ACTION WRITTEN
- 24 May 2023 — USE AMENDMENT ACCEPTED
- 11 Apr 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Apr 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Apr 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Apr 2023 — AMENDMENT TO USE PROCESSING COMPLETE